591 related articles for article (PubMed ID: 28820014)
1. Postinfectious Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and Myelitis.
Vieira JP; Sequeira J; Brito MJ
J Child Neurol; 2017 Oct; 32(12):996-999. PubMed ID: 28820014
[TBL] [Abstract][Full Text] [Related]
2. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection.
Nakamura M; Iwasaki Y; Takahashi T; Kaneko K; Nakashima I; Kunieda T; Kaneko S; Kusaka H
Mult Scler Relat Disord; 2017 Oct; 17():148-150. PubMed ID: 29055448
[TBL] [Abstract][Full Text] [Related]
3. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19.
Zhou S; Jones-Lopez EC; Soneji DJ; Azevedo CJ; Patel VR
J Neuroophthalmol; 2020 Sep; 40(3):398-402. PubMed ID: 32604245
[No Abstract] [Full Text] [Related]
4. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.
Ramanathan S; Prelog K; Barnes EH; Tantsis EM; Reddel SW; Henderson AP; Vucic S; Gorman MP; Benson LA; Alper G; Riney CJ; Barnett M; Parratt JD; Hardy TA; Leventer RJ; Merheb V; Nosadini M; Fung VS; Brilot F; Dale RC
Mult Scler; 2016 Apr; 22(4):470-82. PubMed ID: 26163068
[TBL] [Abstract][Full Text] [Related]
5. [A case of recurrent myelitis associated with anti-myelin oligodendrocyte glycoprotein antibody that developed only as localized short spinal cord lesions].
Matsumoto A; Kaneko K; Takahashi T; Nakashima I; Hisanaga K; Nagano I
Rinsho Shinkeigaku; 2017 Nov; 57(11):729-732. PubMed ID: 29070750
[TBL] [Abstract][Full Text] [Related]
6. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
Chen JJ; Bhatti MT
Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
[TBL] [Abstract][Full Text] [Related]
7. [A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis].
Nagata S; Nishimura Y; Mitsuo K
Rinsho Shinkeigaku; 2018 Oct; 58(10):636-641. PubMed ID: 30270341
[TBL] [Abstract][Full Text] [Related]
8. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis.
Kezuka T; Ishikawa H
Jpn J Ophthalmol; 2018 Mar; 62(2):101-108. PubMed ID: 29445944
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study.
Chen Q; Zhao G; Huang Y; Li Z; Sun X; Lu P; San Y; Wang M; Tian G
Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487
[TBL] [Abstract][Full Text] [Related]
12. [A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy].
Miyazaki T; Nakajima H; Motomura M; Tanaka K; Maeda Y; Shiraishi H; Tsujino A
Rinsho Shinkeigaku; 2016 Apr; 56(4):265-9. PubMed ID: 27010093
[TBL] [Abstract][Full Text] [Related]
13. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
Chen JJ; Flanagan EP; Jitprapaikulsan J; López-Chiriboga ASS; Fryer JP; Leavitt JA; Weinshenker BG; McKeon A; Tillema JM; Lennon VA; Tobin WO; Keegan BM; Lucchinetti CF; Kantarci OH; McClelland CM; Lee MS; Bennett JL; Pelak VS; Chen Y; VanStavern G; Adesina OO; Eggenberger ER; Acierno MD; Wingerchuk DM; Brazis PW; Sagen J; Pittock SJ
Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
[TBL] [Abstract][Full Text] [Related]
14. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
[TBL] [Abstract][Full Text] [Related]
15. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients.
Siritho S; Sato DK; Kaneko K; Fujihara K; Prayoonwiwat N
Mult Scler; 2016 Jun; 22(7):964-8. PubMed ID: 26498263
[TBL] [Abstract][Full Text] [Related]
16. MRI features of demyelinating disease associated with anti-MOG antibodies in adults.
Denève M; Biotti D; Patsoura S; Ferrier M; Meluchova Z; Mahieu L; Heran F; Vignal C; Deschamps R; Gout O; Champfleur NM; Ayrignac X; Dallière CC; Labauge P; Dulau C; Tourdias T; Dumas H; Cognard C; Brassat D; Bonneville F
J Neuroradiol; 2019 Sep; 46(5):312-318. PubMed ID: 31228536
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging in enterovirus-71, myelin oligodendrocyte glycoprotein antibody, aquaporin-4 antibody, and multiple sclerosis-associated myelitis in children.
Tantsis EM; Prelog K; Alper G; Benson L; Gorman M; Lim M; Mohammad SS; Ramanathan S; Brilot F; Dale RC;
Dev Med Child Neurol; 2019 Sep; 61(9):1108-1116. PubMed ID: 30537075
[TBL] [Abstract][Full Text] [Related]
18. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.
Jitprapaikulsan J; Chen JJ; Flanagan EP; Tobin WO; Fryer JP; Weinshenker BG; McKeon A; Lennon VA; Leavitt JA; Tillema JM; Lucchinetti C; Keegan BM; Kantarci O; Khanna C; Jenkins SM; Spears GM; Sagan J; Pittock SJ
Ophthalmology; 2018 Oct; 125(10):1628-1637. PubMed ID: 29716788
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
Nakajima H; Motomura M; Tanaka K; Fujikawa A; Nakata R; Maeda Y; Shima T; Mukaino A; Yoshimura S; Miyazaki T; Shiraishi H; Kawakami A; Tsujino A
BMJ Open; 2015 Apr; 5(4):e007766. PubMed ID: 25838512
[TBL] [Abstract][Full Text] [Related]
20. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
